CapsoVision, Inc.

NASDAQ: CV · Healthcare · Medical - Devices

PublicHQ Saratoga, CA · Santa ClaraCIK 0001378325Reports USD

#594 of 1,418 Healthcare companies by revenue61st-percentile growth

EA Score

37D

FH 49DQ 18GM —SS 46

v0.1 · 55/100 weight · provisional

↑ Altman-Z, balance-sheet leverage · ↓ disclosure history, listing tenure

Methodology →

Revenue TTM

$13.6M

Rev growth YoY (TTM)

+12.6%

Net income (FY)

-$25.3M

Employees

as of 2026-08-12

Market cap

$329.8M

as of 2026-08-12

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$13.6M$13.6M2025

Net income-$25.3M-$25.3M2025

Operating income-$25.5M-$25.5M2025

Total assets$18.2M$18.2M2025

Liabilities$4.9M$4.9M2025

Equity$13.3M$13.3M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is CapsoVision, Inc.’s revenue?

CapsoVision, Inc. booked $13.6M in FY2025 revenue, growing 15% year over year — faster than most Healthcare companies we track, at a -186.8% net margin.

Peers · Healthcare

Biotricity, Inc.——CV Sciences, Inc.56C Hyperfine, Inc.44D Microbix Biosystems Inc.60C Novo Integrated Sciences, Inc.——Mednow Inc.——

Neighbors

Santa Clara →

NVIDIA Corporation$215.9B90A Apple Inc.$416.2B84B+Alphabet Inc.$402.8B81B+Broadcom Inc.$63.9B76B+Advanced Micro Devices, Inc.$34.6B78B+Cisco Systems, Inc.$56.7B85A

Key facts

CEOKang-Huai Wang

SectorHealthcare

IndustryMedical - Devices

HeadquartersSaratoga, CA

ExchangeNASDAQ: CV

Employees99

IPO date2025-07-02

Latest filings

8-K2026-07-02 8-K2026-06-12 10-Q2026-05-14 8-K2026-05-14 DEF 14A2026-04-28 8-K2026-03-26 10-K2026-03-26 8-K2026-03-20

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.